South Korea-based DAAN Biotherapeutics has entered a licensing agreement with GC Cell, granting the latter exclusive rights ...

Invenra Inc., a leader in multispecific antibody discovery and development, today announced the launch of its B-Body Express™ Antibody Expression service. This new offering enables biotechnology and ...

Antibody Solutions, a leading provider of fit-for-purpose antibody discovery services, announced today that for the first time, single plasma B-cell discovery services will be part of the company’s ...

The global antibody discovery market size is anticipated to reach approximately USD 22,570 million by 2034, up from USD 9,570 ...

The sequence homology is over 95%; PTM and aggregation prediction reports are also available 100% success rate As quick as 3–4 weeks to offer required humanized antibodies Affinity evaluated by ...

The resulting antibodies are maximally de-risked with respect to immunogenicity, because every V region sequence has been expressed in a human body before. This, in combination with the early de ...

“Integrated with single cell sequencing technology, the target antibody sequences can be easily obtained. This reduces the cycle of the whole process, from defining the target to generating ...

Single-cell RNA sequencing then identifies the sequences of antibodies that cause these diseases. “Next, we re-engineer IgE antibodies into IgG antibodies that can protect from, rather than ...

In the landmark Amgen v. Sanofi case (previously covered here), the Supreme Court affirmed that patent claims drawn to a genus of ...

Monoclonal antibodies are considered the most rapidly growing class of therapeutics. Critical quality attributes such as sequence assessment, charge and size variants must be thoroughly monitored ...